La ATC es una alternativa válida en el TCI

Left Main Coronary Artery Percutaneous Coronary Intervention: Evolution and Results over Time

Left main coronary artery percutaneous coronary intervention (LMCA PCI) is a treatment option that is increasingly used in our setting. One of the reasons for choosing this therapeutic strategy is the improvements in devices and techniques. However, the long-term results of LMCA PCI are not well established. The aim of this retrospective study was to<a href="https://solaci.org/en/2023/01/31/left-main-coronary-artery-percutaneous-coronary-intervention-evolution-and-results-over-time/" title="Read more" >...</a>

Evaluación funcional de las estenosis coronarias en la vida real: todavía no hicimos el click.

Left Main Coronary Artery PCI Using State-of-the-Art Zotarolimus-Eluting Stents

Percutaneous coronary intervention (PCI) to the left main coronary artery (LMCA) with drug-eluting stent implantation is currently a major challenge due to the size of the vessel, the compromise of a bifurcation lesion in important branches, and the potential risk of complications. Available information on LMCA PCI comes from studies where DES stents were implanted<a href="https://solaci.org/en/2023/01/18/left-main-coronary-artery-pci-using-state-of-the-art-zotarolimus-eluting-stents/" title="Read more" >...</a>

ATC sobre arterias nativas o puentes venosos, ¿cuál tiene mejor pronóstico?

Real-World Revascularization Strategy for Left Main Coronary Artery: Surgery or PCI?

There are many current randomized trials comparing percutaneous coronary intervention (PCI) with myocardial revascularization surgery (MRS) for the treatment of left main coronary artery disease (LMCAD). In the European Society of Cardiology guidelines, PCI is classified as Ia (LMCAD with low-complexity coronary disease) or IIa indication (intermediate complexity), whereas, according to the American Heart Association<a href="https://solaci.org/en/2023/01/11/real-world-revascularization-strategy-for-left-main-coronary-artery-surgery-or-pci/" title="Read more" >...</a>

AHA 2021 | Meta-análisis de cirugía vs angioplastia para el tronco de la coronaria izquierda

AHA 2021 | Meta-Analysis of Surgery vs. Angioplasty in Left Main Coronary Artery Disease

According to this new meta-analysis (presented at AHA 2021 and published in The Lancet), mortality is similar between surgery and angioplasty to treat left main coronary artery in patients with simple or intermediate anatomy. This new study estimates that, after 5 years, mortality with surgery would be 11.2% vs. 10.2% with angioplasty, a non-significant difference. This debate<a href="https://solaci.org/en/2021/11/25/aha-2021-meta-analysis-of-surgery-vs-angioplasty-in-left-main-coronary-artery-disease/" title="Read more" >...</a>

Webinar SOLACI 03-03 | Angioplastia de Tronco de Coronaria Izquierda y Bifurcaciones: Registro LATAM Bif

Watch again our Webinar on Left Main PCI and Bifurcations: LATAM Bif Registry

Watch again our Webinar on “Left Main PCI and Bifurcations: LATAM Bif Registry” on our Youtube account. The event was held on March 3rd, 2021, and had the participation of almost 700 people and the support of ABBOTT, Boston Scientific, Medtronic and Terumo. Webinar Contents 00:02 | Introduction – Dr. José Mangione (BRA). 04:58 |<a href="https://solaci.org/en/2021/03/04/watch-again-our-webinar-on-left-main-pci-and-bifurcations-latam-bif-registry/" title="Read more" >...</a>

03/03 | SOLACI Webinar – Left Main PCI and Bifurcations: LATAM Bif Registry

We invite you to participate in the first free SOLACI virtual event of 2021. It is carried out with the support of Abbott, Boston Scientific, Medtronic and Terumo Interventional Systems and will have the participation of prestigious hemodynamicists from Latin America and the world. The title of the event is: “Left Main PCI and Bifurcations:<a href="https://solaci.org/en/2021/03/01/03-03-solaci-webinar-left-main-pci-and-bifurcations-latam-bif-registry/" title="Read more" >...</a>

Does Surgeon (Instead of Operator) Experience Affect TAVR?

There is a correlation between the volume of conventional surgical aortic valve replacement procedures and better outcomes in transcatheter aortic valve replacement (TAVR), with higher 30-day and 1-year mortality in sites with lower volume. This is a probable indication that a good surgical team is complemented by a good hemodynamic team and, ultimately, a good<a href="https://solaci.org/en/2020/05/08/does-surgeon-instead-of-operator-experience-affect-tavr/" title="Read more" >...</a>

Ecuador Regional Sessions 2020: See the Presentations

The 40th Regional Sessions held in Ecuador in 2020 was a successful scientific event that counted with the participation of reputed Latin American interventionists. We want to express our gratitude to all participants, attendees and representatives of the industry who contributed to the highest quality of this event.  Next, we share some of the presentations<a href="https://solaci.org/en/2020/04/13/ecuador-regional-sessions-2020-see-the-presentations/" title="Read more" >...</a>

TCT 2019 | EXCEL: Left Main Coronary Artery Angioplasty with Favorable Results at 5 Years

Courtesy of Dr. Carlos Fava. Unprotected left main coronary artery angioplasty with drug-eluting stents has emerged as an acceptable strategy for a select group of patients, with results comparable to those of myocardial revascularization surgery at 2 or 3 years. However, beyond such term, we had no valid information. Researchers analyzed the 5-year follow-up results for the<a href="https://solaci.org/en/2019/10/01/tct-2019-excel-left-main-coronary-artery-angioplasty-with-favorable-results-at-5-years/" title="Read more" >...</a>

angioplastia a tronco de coronaria izquierda vs cirugia

Surprising EXCEL Outcomes in Diabetics with Main Left Stenosis

This study especially designed to compare PCI vs. CABG in patients with left main coronary artery disease and low to intermediate Syntax score showed that 30-day and 3 -year outcomes of PCI with everolimus eluting stents vs CABG were consistent both in diabetic and non-diabetic patients. The randomized EXCEL trial (Evaluation of XIENCE versus Coronary<a href="https://solaci.org/en/2019/05/09/surprising-excel-outcomes-in-diabetics-with-main-left-stenosis/" title="Read more" >...</a>

angioplastia de tronco da coronária